CK Life Sciences sold the stake/assets to TransCode Therapeutics as part of a acquisition on not available.
Deal value was 3200000000 (source: AI Estimation) Sector: Biotechnology; Location: Global.
On the seller side, not available advised, led by Grace Huang, Heather Brookfield, Kyle Lakin, Pam Marcogliese, Sebastian Fain, Steven Li, Vinita Kailasanath.
Generated by AI, original source from - Data is in progress
Found it useful? Spread the word.
Freshfields advises CK Life Sciences on sale of Polynoma to TransCode Therapeutics | The Sponsor - The Sponsor
